Symbol
KLRS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
201,718 shares
Security Ownership %
1.1%
Shares, Excluding Options vs Price
Value, Excluding Options

EcoR1 Capital, LLC ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

15 May 2025 - EcoR1 Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 201,718 shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS). This represents 1.1% ownership of the company. This is the first filing by EcoR1 Capital, LLC disclosing ownership of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.